XUNCE(03317.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 72.51 million, turned profitable from a loss YoY

August 21, 2026, XUNCE(03317.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 967.02 million, increased by 388.78% YoY; Net Profit stood at CNY 67 million, turned profitable from a loss YoY; Profit Attributable to Shareholders stood at CNY 72.51 million, turned profitable from a loss YoY; Basic Earnings Per Share (EPS) stood at CNY 0.22.
In terms of profitability, XUNCE Gross Profit changed from CNY 131.88 million in the same period last year to CNY 580.91 million in the current period, increased by CNY 449.03 million; gross profit margin changed from 66.66% in the same period last year to 60.07% in the current period, decreased by 6.59 percentage points; net profit changed from loss of CNY 108 million in the same period last year to CNY 67 million in the current period, increased by CNY 175 million; net profit margin changed from -54.59% in the same period last year to 6.93% in the current period, increased by 61.52 percentage points.
In terms of earnings quality, XUNCE Operating Profit changed from loss of CNY 106.79 million in the same period last year to CNY 69.06 million in the current period, increased by CNY 175.85 million; Operating Profit Margin changed from -53.98% in the same period last year to 7.14% in the current period, increased by 61.12 percentage points.
In terms of financial soundness, XUNCE Debt-to-Asset Ratio changed from 12.36% in the same period last year to 29.36% in the current period, increased by 17 percentage points; Total Equity changed from CNY 1.543 billion in the same period last year to CNY 2.482 billion in the current period, increased by CNY 938.59 million; Current Liabilities changed from CNY 193.56 million in the same period last year to CNY 891.2 million in the current period, increased by CNY 697.64 million.
In terms of R&D investment focus, XUNCE R&D Expenses changed from CNY 168.1 million in the same period last year to CNY 396.59 million in the current period, increased by CNY 228.49 million; R&D to Total Revenue Ratio changed from 84.96% in the same period last year to 41.01% in the current period, decreased by 43.95 percentage points.
By the close of trading on August 21, 2026, XUNCE(03317) saw a gain of 2.08% in its share price, closing at HKD 137.1. During the session, it reached an intraday high of HKD 140.6. The full-day turnover stood at HKD 325.22 million, with the latest market capitalization at HKD 37.63 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.